RxDoctor Payments Data

Nabeel Khan, MD

Gastroenterology · Southaven, MSNPI 1154490282

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (46.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Pharmacosmos Therapeutics Inc. accounts for 63.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $9,612 and has fallen 83.4% since, to $1,600 in 2025. Among gastroenterology clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,775in general payments, 2019–2025

Across 25 payments — averaging $911.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharmacosmos Therapeutics Inc.$14K
  • Takeda Pharmaceuticals U.S.A., Inc.$6K
  • Alcresta Therapeutics, Inc.$2K
  • AbbVie$863
  • Janssen Scientific Affairs, LLC$125
  • Merck$19
  • plus $29 from 2 others
$533,240in research payments, 2019–2025

Across 18 payments — averaging $29,624 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$472K
  • Takeda$61K

What the payments were for

  • Consulting fees$10,54046%
  • Speaking & faculty fees$8,10036%
  • Travel & lodging$3,29014%
  • Food & beverage$8454%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,775 in reported general payments places this provider in the 90th percentile of 127 gastroenterology providers in Mississippi.

See all gastroenterology providers in Mississippi

Medicare billing

Part B allowed, 2024
$8,859
Medicare patients
52
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Southaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →